CI

At a glance

ClinicalIndex Comparison Record
Phase 3Completed· 118 enrolled
Drug / intervention
Progressive Addition Lenses (PALs) +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00320593
NCT00320593Phase 3Completed
CompareCT.gov

Correction of Myopia Evaluation Trial 2 (COMET2): A Randomized Trial of the Effect of Progressive Addition Lenses Versus Single Vision Lenses on Low Myopia Associated With Large Accommodative Lags and Near Esophoria in Children

Jaeb Center for Health Research·interventional·Posted May 3, 2006·Updated Jul 19, 2016

In Brief

A Phase 3 clinical trial evaluating Progressive Addition Lenses (PALs) and Single Vision Lenses (SVLs) for Myopia. Completed, enrolled 118 participants across 8 sites.

Detailed Summary

The purpose of the study is to determine if progressive addition lenses (PALs) versus single vision lenses (SVLs) slow the progression of low myopia in children with poor accommodative responses (i.e., large accommodative lags) and near esophoria.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsMyopia
CountriesUnited States
CollaboratorsNational Eye Institute (NEI)

Timeline

Phase 3CompletedFinished
20052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedMay 3, 2006
Enrollment StartApr 1, 2005
Primary CompletionMar 1, 2010
TodayJul 2, 2026
Enrollment to primary: 4.9 yearsPosted 20.2 years ago

Interventions

Progressive Addition Lenses (PALs)device

Varilux Ellipse progressive addition lenses (PALs) with a +2.00 D addition

Single Vision Lenses (SVLs)device

Single vision lenses